Latest Quarter
Q2 FY2026ended 2026-06-30 · filed 2026-08-10
$972.52M
$19.74M
$34.32M
$0.40
$400.79M
$2.28B
$830.22M
$882.65M
What this quarter tells us
For Q1 FY2025 (ended March 31, 2026), Astrana Health reported revenue of $965.1 million, up 55.6% year-over-year. Net income was $14.4 million, a 115.7% increase, while diluted EPS rose 107.1% to $0.29. Operating income grew 38.6% to $28.5 million. The company had $478.4 million in cash, $800.3 million in equity, and $979.8 million in long-term debt.
- •Revenue surged 55.6% YoY to $965.1M.
- •Net income more than doubled, up 115.7% to $14.4M.
- •Diluted EPS increased 107.1% to $0.29.
- •Operating income grew 38.6% to $28.5M.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.